<bill session="109" type="h" number="1083" updated="2013-07-19T19:13:44-04:00">
  <state datetime="2005-03-03">REFERRED</state>
  <status>
    <introduced datetime="2005-03-03"/>
  </status>
  <introduced datetime="2005-03-03"/>
  <titles>
    <title as="introduced" type="short">Methamphetamine Reduction Act of 2005</title>
    <title as="introduced" type="official">To amend the Controlled Substances Act with respect to the regulation of ephedrine alkaloids, including ephedrine and pseudoesphedrine.</title>
  </titles>
  <sponsor id="400645"/>
  <cosponsors>
    <cosponsor id="400006" joined="2005-07-26"/>
    <cosponsor id="400077" joined="2005-03-03"/>
    <cosponsor id="400197" joined="2005-11-07"/>
    <cosponsor id="400226" joined="2005-09-28"/>
    <cosponsor id="400642" joined="2005-09-08"/>
    <cosponsor id="400316" joined="2005-07-21"/>
    <cosponsor id="400340" joined="2005-07-21"/>
    <cosponsor id="400361" joined="2005-07-26"/>
    <cosponsor id="400421" joined="2005-06-24"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2005-03-03">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2005-03-03">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2005-03-03">
      <text>Referred to House Judiciary</text>
    </action>
    <action datetime="2005-03-22">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
    <action datetime="2005-04-04">
      <text>Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.</text>
      <committee name="House Judiciary"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSJU" name="House Judiciary" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSJU08" subcommittee="Crime, Terrorism, and Homeland Security" name="House Judiciary"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Chemicals"/>
    <term name="Commerce"/>
    <term name="Drug abuse"/>
    <term name="Drug industry"/>
    <term name="Drug law enforcement"/>
    <term name="Drug traffic"/>
    <term name="Drugs"/>
    <term name="Health"/>
    <term name="Methamphetamine"/>
  </subjects>
  <amendments/>
  <summary>3/3/2005--Introduced.
Methamphetamine Reduction Act of 2005 - Requires ephedrine alkaloids, including ephedrine and pseudoephedrine, to be listed in schedule V (drugs or other substances having a low potential for abuse, that have a currently accepted medical use in treatment in the United States, abuse of which may lead to limited physical or psychological dependence) of the Controlled Substances Act. Excepts ephedrine alkaloid when contained in a drug that: (1) is marketed or distributed lawfully in the United States under the Federal Food, Drug, and Cosmetic Act; and (2) cannot be easily used in the illicit production of methamphetamine. Provides that an ephedrine alkaloid when so contained shall be considered a listed chemical.</summary>
</bill>
